申请人:Adir et Compagnie
公开号:US06133454A1
公开(公告)日:2000-10-17
The present invention relates to a process for the industrial synthesis of a substituted perhydroisoindole of formula (I): ##STR1## and of pharmaceutically acceptable salts thereof. The compound of formula (I) and its addition salts have especially valuable pharmacological properties. It is a very powerful secretor of insulin, which makes it useful in the treatment of non-insulin-dependent diabetes.
本发明涉及一种用于工业合成式(I)的取代过氢异吲哚的过程: ##STR1## 以及其药学上可接受的盐。式(I)化合物及其加成盐具有特别有价值的药理学特性。它是一种非常强大的胰岛素分泌剂,因此在治疗非胰岛素依赖性糖尿病方面非常有用。